Cargando…
Gut Microbiota is an Impact Factor based on the Brain-Gut Axis to Alzheimer’s Disease: A Systematic Review
Alzheimer’s disease (AD) is a degenerative disease of the central nervous system. The pathogenesis of AD has been explained using cholinergic, β-amyloid toxicity, tau protein hyperphosphorylation, and oxidative stress theories. However, an effective treatment method has not been developed. In recent...
Autores principales: | Zou, Bin, Li, Jia, Ma, Rui-Xia, Cheng, Xiao-Yu, Ma, Rui-Yin, Zhou, Ting-Yuan, Wu, Zi-Qi, Yao, Yao, Li, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187701/ https://www.ncbi.nlm.nih.gov/pubmed/37191418 http://dx.doi.org/10.14336/AD.2022.1127 |
Ejemplares similares
-
Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy via the gut-liver-brain axis
por: Luo, Ming, et al.
Publicado: (2023) -
Brain-Gut-Microbiota Axis in Alzheimer’s Disease
por: Kowalski, Karol, et al.
Publicado: (2019) -
The neuromodulatory effects of flavonoids and gut Microbiota through the gut-brain axis
por: Wang, Haoran, et al.
Publicado: (2023) -
Functional roles of the microbiota-gut-brain axis in Alzheimer’s disease: Implications of gut microbiota-targeted therapy
por: Zhong, Si-Ran, et al.
Publicado: (2021) -
Role of gut microbiota via the gut-liver-brain axis in digestive diseases
por: Ding, Jian-Hong, et al.
Publicado: (2020)